These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6888533)

  • 1. Cancer chemotherapy: new recruits.
    David P
    Nature; 1983 Aug 25-31; 304(5928):675. PubMed ID: 6888533
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials referral resource. Current clinical trials of bortezomib.
    Wright JJ; Zerivitz K; Schoenfeldt M
    Oncology (Williston Park); 2003 May; 17(5):677-80, 683-6, 691-2. PubMed ID: 12800794
    [No Abstract]   [Full Text] [Related]  

  • 4. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 5. The national program for cancer chemotherapy.
    Zubrod CG
    JAMA; 1972 Nov; 222(9):1161-2. PubMed ID: 4678048
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 7. The National Cancer Chemotherapy Program.
    Frei E
    Science; 1982 Aug; 217(4560):600-6. PubMed ID: 7046055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational new drugs in cancer chemotherapy.
    Peterson BA; Briscoe K
    Minn Med; 1979 Jul; 62(7):536-8. PubMed ID: 386073
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecule of the month. Bortezomib.
    Drug News Perspect; 2003 Jun; 16(5):324. PubMed ID: 12942163
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncology clinical trials.
    Mellody P; Dehgan A
    Case Manager; 1999; 10(3):73-5. PubMed ID: 11061127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins and development of chemotherapy research at the National Cancer Institute.
    Zubrod CG
    Cancer Treat Rep; 1984 Jan; 68(1):9-19. PubMed ID: 6362871
    [No Abstract]   [Full Text] [Related]  

  • 12. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract]   [Full Text] [Related]  

  • 13. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the report of the 1966 Cancer Chemotherapy Collaborative Program Review Committee.
    Richardson AP
    Cancer Treat Rep; 1984 Jan; 68(1):340-1. PubMed ID: 6692434
    [No Abstract]   [Full Text] [Related]  

  • 16. NCI's cancer therapy evaluation program: a commitment to treatment trials.
    Abrams JS; Murgo A; Christian MC
    Cancer Treat Res; 2007; 132():31-50. PubMed ID: 17305016
    [No Abstract]   [Full Text] [Related]  

  • 17. The limited precision of phase I trials.
    Christian MC; Korn EL
    J Natl Cancer Inst; 1994 Nov; 86(22):1662-3. PubMed ID: 7966387
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials referral resource. Current clinical trials of G3139.
    Tock B; Zwiebel JA; Schoenfeldt M
    Oncology (Williston Park); 2003 Sep; 17(9):1244-6, 1251-3, 1258. PubMed ID: 14569852
    [No Abstract]   [Full Text] [Related]  

  • 19. The search for therapeutic cell controls by the chemotherapy program of the National Cancer Institute.
    Carter SK
    J Invest Dermatol; 1972 Jul; 59(1):128-38. PubMed ID: 4557098
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing access to investigational drugs.
    Christian M
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):90-1. PubMed ID: 16163167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.